Vivitra 150 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Vivitra 150 mg Injection

Vivitra 150 mg Injection

Vivitra 150 mg Injection contains trastuzumab, a targeted monoclonal antibody used mainly for HER2-positive breast and gastric cancers. It is supplied as a 150 mg injection and is administered by intravenous infusion under medical supervision. Trastuzumab targets the HER2 protein and helps slow the growth of HER2-positive cancer cells.

BUY NOW

Category

Vivitra 150 mg Injection is a biosimilar trastuzumab product used in selected HER2-positive breast cancer and metastatic gastric cancer treatment protocols. It binds to HER2 receptors on cancer cells and interferes with signals that support their growth and survival. The medicine is administered by a trained healthcare professional according to the prescribed oncology regimen. Patients should be monitored for infusion-related reactions and potential cardiac effects during treatment.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 150 mg
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer Zydus Lifesciences Limited

Product Also Known As

Vivitra 150 mg Injection, Vivitra 150 Injection, Vivitra Trastuzumab Injection, Trastuzumab 150 mg Injection, Trastuzumab Cancer Injection, HER2 Targeted Cancer Injection